CXCL1 promotes colon cancer progression through activation of NF-&#954;B/P300 signaling pathway.

Zhuo, Changhua; Ruan, Qiang; Zhao, Xiangqian; Shen, Yangkun; Lin, Ruirong

CXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway.

Zhuo, Changhua; Ruan, Qiang; Zhao, Xiangqian; Shen, Yangkun; Lin, Ruirong.

Afiliação

Zhuo C; Department of Gastrointestinal Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, 350014, People's Republic of China. czhuo12@outlook.com.
Ruan Q; Fuzhou University, College of Chemistry, Fuzhou, 350108, People's Republic of China. czhuo12@outlook.com.
Zhao X; Fujian Key Laboratory of Translational Cancer Medicine and Fujian Provincial Key Laboratory of Tumor Biotherapy, Fuzhou, Fujian, 350014, People's Republic of China. czhuo12@outlook.com.
Shen Y; Fuzhou University, College of Chemistry, Fuzhou, 350108, People's Republic of China.
Lin R; Fujian Normal University Qishan Campus, College of Life Science, Biomedical Research Center of South China, Fuzhou, 350117, People's Republic of China.

Biol Direct ; 17(1): 34, 2022 11 25.

Article em En | MEDLINE | ID: mdl-36434686

Assuntos

Neoplasias do Colo; Neoplasias Colorretais; Humanos; NF-kappa B/metabolismo; NF-kappa B/farmacologia; Transdução de Sinais; Neoplasias do Colo/genética; Neoplasias Colorretais/metabolismo; Quimiocina CXCL1/genética; Quimiocina CXCL1/metabolismo; Quimiocina CXCL1/farmacologia

Palavras-chave

C646; CXCL1; Colon cancer; NF-κB; P300

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias do Colo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Biol Direct Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google